HCA
GSK icon

Horan Capital Advisors’s GSK GSK Stock Holding History

Horan Capital Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$5K – 156
2020
Q3 		$5K Buy
+100
New +$5.01K ﹤0.01% 274
2020
Q1 		– Sell
-100
Closed -$6K – 145
2019
Q4 		$6K Hold
100
– – ﹤0.01% 236
2019
Q3 		$5K Buy
+100
New +$5.14K ﹤0.01% 244

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Horan Capital Advisors's GSK Position: Q4 2020 in Review

Horan Capital Advisors sold out of GSK (GSK) in Q4 2020, closing a stake of 100 shares — an estimated $5K sold.

Horan Capital Advisors first reported a position in GSK in Q3 2019 and held it in 3 quarters. The position peaked at $6K in Q4 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • Horan Capital Advisors reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • Horan Capital Advisors sold 100 GSK shares in Q4 2020, an estimated $5K.
  • Horan Capital Advisors first reported a position in GSK in Q3 2019 and held it in 3 quarters.
  • Horan Capital Advisors's GSK position peaked at $6K in Q4 2019.
  • 818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Horan Capital Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.